Indiana University Melvin and Bren Simon Cancer Center

About Us

Mission & Goals Milestones Senior Leaders Facts Community Outreach Resources Partners & Clinical Affliates Travel Information Facilities New Construction People Search Employment

You are here: HOME > About Us > Partners

Partners & Clinical Affiliates

Partners

The IU Simon Cancer Center partners with several Indiana University and Purdue University schools and centers, private organizations, as well as a local hospital system to conduct its patient care, research and education. These partnerships bring together talents and resources, and strengthens efforts that are aimed at reducing the burden of cancer in Indiana and beyond.

Hoosier Oncology Group (HOG) is an innovative program that encourages community physicians to conduct clinical trials. It aims to increase community access to research opportunities. HOG was co-founded by Patrick J. Loehrer Sr., MD. There are more than 400 HOG physicians from eight different states, but the vast majority practice in Indiana.

Indiana University Center for Environmental Health fosters excellence in scientific research, training, and outreach in environmental health. The induction and progression of most chronic  human disease, including cancer, involves an interaction of between genetics and environment (including lifestyle). A goal of the Center for Environmental Health is to identify and understand this interaction in the cause and prevention of disease covering the human life span.

Indiana University Center for Health Services & Outcomes Research (CHSOR) is an IUPUI campus-wide center funded by Indiana University School of Medicine, the Regenstrief Institute Inc., and the Roudebush VA Medical Center. The mission of the CHSOR is to foster research in accelerating the transformation of healthcare organizations and improving the organization, delivery and outcomes of healthcare. IU Simon Cancer Center member Brad Doebbeling, MD, MSc, is the center’s director. 

IU Health is composed of the hospitals and clinics of Indiana University School of Medicine, IU Health University Hospital, Riley Hospital for Children and Methodist Hospital. IU Health is committed to excellence in patient care, education and research. Click here for the IU Health Cancer Program team.

The Indiana University Health Proton Therapy Center, formerly Midwest Proton Radiotherapy Institute, is a state-of-the-art center offering proton therapy: a highly precise mechanism of treating cancer. Since February 2004, the medical team has treated adults and children with both benign and cancerous tumors, specializing in cancers of the head, neck, spine, and prostate. Located on the Indiana University Bloomington campus, the IU Health Proton Therapy Center is the third of nine high-energy proton centers currently operating in the United States and is the first facility in the Midwest. It is programmatically incorporated into the IU Simon Cancer Center. Physician and self referrals are welcome.

Indiana University School of Medicine is the only institution that provides medical education within the state of Indiana. It is committed to providing quality graduate and continuing education that produces outstanding educators, physicians, and scientists; conducting research to advance knowledge of health and behavior and to make discoveries leading to improved prevention and treatment of disease; and providing outstanding clinical care, which incorporates the latest advances in scientific knowledge. Many IU Simon Cancer Center members are IU School of Medicine faculty. The IU Simon Cancer Center collaborates with numerous research institutes and centers of excellence within the IU School of Medicine.

Oncological Sciences Center at Purdue University's Discovery Park has adopted the mission to eliminate cancer as a cause of suffering and death by synergizing and applying the internationally recognized strengths of Purdue University in biological, chemical, engineering and human behavioral sciences to the cancer problem. The Oncological Sciences Center builds in new directions and exciting ways on a foundation laid in place through decades of discoveries and advances in the laboratories of members of Purdue's NCI-designated Cancer Center.

Purdue University Center for Cancer Research is an NCI-designated Cancer Center in West Lafayette, Ind., that conducts basic research. It is committed to helping cancer patients by identifying new molecular targets and designing future agents and drugs for effectively detecting and treating cancer. Research programs at the center are divided into four areas: cell growth and differentiation; chemical and structural biology, medicinal chemistry and drug delivery and molecular sensing.

Susan G. Komen for the Cure Tissue Bank at the IU Simon Cancer Center's goals are to acquire biomolecule and tissue specimens from the entire continuum of breast development: puberty to menopause and to make these specimens or the digital data derived from them available and accessible to researchers across the globe.

VA Center of Excellence on Implementing Evidence-Based Practice (CIEBP) is a national resource with a mission to discover, implement and sustain the adoption of best practices, using health information technology (HIT), to improve healthcare delivery. The center’s goal is to enhance the VA’s organizations and networks capacity for data-driven decision making and to implement and sustain best practices. IU Simon Cancer Center member Brad Doebbeling, MD, MSc, is the center’s founding director. 

Walther Cancer Foundation (WCF) is an independent, private grant-making foundation committed to eliminating cancer as a cause of suffering and death through supporting and promoting interdisciplinary and inter-institutional basic laboratory, clinical, and behavioral cancer research. The foundation is particularly interested in supporting efforts to strengthen cancer research institutions in Indiana. WCF believes that cancer research provides tangible benefits in expanding our base of knowledge, saving lives, and offering hope to patients and their families. Since its founding in 1985, the Walther Cancer Foundation has invested almost $100 million in cancer-focused medical research.

Clinical Affiliates

The Indiana University Melvin and Bren Simon Cancer Center has clinical affiliation agreements with Memorial Hospital and Health Care Center (Jasper, Ind.) and Good Samaritan Hospital (Vincennes, Ind.). The agreements give the Jasper and Vincennes hospitals priority access to the resources and services of the IU Simon Cancer Center, an IU School of Medicine and IU Health partnership. The affiliation includes clinical, research, and educational components.

• The clinical component ensures priority access to IU Simon Cancer Center, its reports and results to the referring physicians and their patients at Memorial Hospital and Good Samaritan Hospital and makes IU Simon Cancer Center physicians available for second opinions.
• The research component makes it possible for Jasper and Vincennes patients to enroll in clinical trials at the IU Simon Cancer Center and through the Hoosier Oncology Group, a working association of IU medical center physicians and 400 oncologists statewide.
• The educational component allows the Japser and Vincennes staffs to have educational opportunities, including participation in grand rounds and conferences, special education venues, lectures by IU faculty and training for non-physician staff.